Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 18/20 | 0.43 |
| ▸ | SLC6A4 | P31645 | 18/20 | 0.43 |
| ▸ | SLC6A3 | Q01959 | 4/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.36 |
| ▸ | P2RX4 | Q99571 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5112330 | 0.95 | SLC6A2 (0.42) | SLC6A2SLC6A4SLC6A3KMT2A | |
| SCHEMBL4690066 | 0.82 | SLC6A2 (0.54) | SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL4479507 | 0.79 | SLC6A2 (0.48) | SLC6A2SLC6A4SLC6A3CYP2D6KCNH2 | |
| SCHEMBL5440605 | 0.78 | SLC6A2 (0.47) | SLC6A2SLC6A4SLC6A3KMT2ACYP2D6 | |
| SCHEMBL5925320 | 0.76 | SLC6A2 (0.53) | SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL4687364 | 0.75 | PGR (0.43) | SLC6A2SLC6A4SLC6A3KMT2ACYP2D6 | |
| SCHEMBL5112323 | 0.73 | SLC6A2 (0.41) | SLC6A2SLC6A4SLC6A3CYP2D6 | |
| SCHEMBL5127976 | 0.73 | SLC6A2 (0.52) | SLC6A2SLC6A4SLC6A3KMT2A | |
| SCHEMBL4487295 | 0.73 | SLC6A4 (0.39) | SLC6A2SLC6A4SLC6A3KMT2ACYP2D6 | |
| Cadaverine Tartrate SCHEMBL4477830 | 0.71 | SLC6A2 (0.58) | SLC6A2SLC6A4SLC6A3CYP2D6KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1638934-B1 | 3-AMINOPYRROLIDINES AS INHIBITORS OF MONOAMINE UPTAKE | LILLY CO ELI (US) | 2008-01-09 | — | — | EP | disclosed |